Aspergillosis of lung
ICD-10 B48.2 is a billable code used to indicate a diagnosis of aspergillosis of lung.
Aspergillosis of the lung is a fungal infection caused by the Aspergillus species, primarily Aspergillus fumigatus. This condition typically occurs in individuals with compromised immune systems, such as those with chronic lung diseases, cancer, or those undergoing immunosuppressive therapy. The infection can manifest in various forms, including allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), and invasive aspergillosis. Symptoms may include cough, hemoptysis, fever, and chest pain. Diagnosis is often confirmed through imaging studies, such as CT scans, and microbiological cultures. Treatment usually involves antifungal medications, such as voriconazole or amphotericin B, and may require surgical intervention in severe cases. The prognosis varies based on the patient's immune status and the extent of lung involvement.
Detailed history of respiratory symptoms, imaging results, and treatment plans.
Patients with chronic lung disease presenting with worsening respiratory symptoms.
Ensure clear documentation of the patient's immune status and any prior lung conditions.
Comprehensive records of laboratory results, antifungal therapy, and patient follow-up.
Immunocompromised patients with suspected fungal infections.
Document the rationale for antifungal choice and any adverse reactions.
Used in outpatient settings for treating aspergillosis.
Document the indication for use and patient response.
Pulmonologists should document the patient's lung function and any side effects.
Common symptoms include cough, hemoptysis, fever, chest pain, and difficulty breathing, particularly in immunocompromised patients.
